• Allergy

  • Cold

  • Cough

  • Opioid Analgesic




  • management of mild to moderate pain

  • Antitussive in small doses

  • Off label use = management of diarrhea




  • binds opiate receptors in the CNS

  • Alters perception and response to pain stimuli

  • general CNS depressant

  • depresses cough reflex

  • Decreases GI motility




  • Hypersensitivity

  • Head Trauma

  • Increased Intracranial pressure

  • severe renal hepatic or renal pulmonary disease

  • hypothryroidism

  • adrenal insufficiency

  • alcoholism

  • Geri or debilitated: dose reduction, increased susceptibility to CNS depression and constipation

  • Geri: Prostatic Hyperplasia

  • OB: use during labor, respiratory depression may occur in newborn


Adverse Rxns/Side Affects


  • confusion

  • sedation

  • dysphoria

  • euphoria

  • floating feeling

  • hallucinations

  • headache

  • unusual dreams

EENTeyes, ears, nose and throat

  • blurred vision

  • diplopia

  • miosis (constriction of the pupil of the eye.)



  • Respiratory depression


  • hypotension

  • bradycardia


  • constipation

  • nausea

  • vomiting


  • urinary retention


  • Flushing

  • Diaphoresis


  • Physical Dependence

  • psychological dependence

  • tolerance




  • MAO inhibitors (reduce initial dose to 25% of usual dose)


Additive CNS depression with:

  • alcoholics
  • antidepressants
  • antihistamines

  • sedative/hypnotics


Antagonistic effects (partial)

  • buprenorphine

  • butorphanol

  • nalbuphine

  • pentazocine

  • may ppt withdrawal in physically dependent patients


Nalbuphine and pentazocine may decrease analgesia



  • IV

  • IM

  • PO




  • assess BP Pulse, Resp before and during administration

  • If resp is <10/min assess lvl of sedation

  • Initial drowsiness may diminish with subsequent use

  • Assess bowel function: increase fluid intake, bulk and laxatives

  • Simulant laxatives should be administered routinely if opioid use exceeds 2-3 days



  • assess pain type, location and intensity before and 1hr after administration (peak)

  • increases of 25-50% should be administered until there is either a 50% decrease in numerical pain scale reported or pt reports satisfactory relief

  • An equianalgesic chart should be used when changing from one analgesic to another


Antidote: Narcan


Patient Teaching:


  • may cause drowsiness caution against driving or other activities that require high alertness

  • advise pt to change position slowly to avoid orthstatic hypotension

  • caution pt to turn, cough, breath deeply every 2hr to avoid atelectasis

  • Good oral hygiene, mouth rinse and sugarless gum may decrease fry mouth

Hazard Vallerand, April,  and Hopfer Deglin , Judith. 2007. Davis` Drug Guide for Nurses. 11th ed. F. A Davis Company, USA.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: